DocDollars

Organogenesis Inc.

MA · United States · Reporting entity ID 100000011175

Total reported 2019–2025
$17.4M
#352 of 2,960 reporting companies — 0% of all reported industry payments
$13.4M in general payments across 142,712 records, plus $3.98M in research funding across 407 records.

How it breaks down

General payments $13,406,336
Research funding $3,981,538

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Organogenesis Inc. reported $17.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #352 of 2,960 reporting companies. 23% of that was research funding and 77% general payments such as consulting, speaking, food and travel. 142,712 general payment records and 407 research records were filed.

Common questions about Organogenesis Inc.

How much has Organogenesis Inc. paid US doctors?

Organogenesis Inc. reported $17,387,874 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $13,406,336 in general payments, $3,981,538 in research funding.

How does Organogenesis Inc. rank among drug and device companies?

It ranks #352 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Organogenesis Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.